Femme et Homme
- | Pays :
- Australia
- Czech Republic
- Germany
- Les 7 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a randomized trial to estimate the activity of R-ICE plus SGN-40 vs. R-ICE plus placebo in patients with DLBCL. The study will assess safety and tolerability and will measure any additional clinical benefit observed in patients receiving SGN-40.
Critère d'inclusion
- Lymphoma, Large B-Cell, Diffuse ,Lymphoma. Non-Hodgkin